Article

p16INK4a: A central player in cellular senescence and a promising aging biomarker in elderly cancer patients

2011-09-20

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dd3ae0ce-7e83-5731-9217-becf7f91fcc3
DOI: 10.1016/j.jgo.2011.08.004

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

p16INK4a: A central player in cellular senescence and a promising aging biomarker in elderly cancer patientsDOI 10.1016/j.jgo.2011.08.004Read

The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancerSemantic proximity Read

The Role of p16Ink4a as an Early Predictor of Physiological Decline during Natural AgingSemantic proximity Read

Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidneySemantic proximity Read

Aberrant expression of p16INK4a in human cancers – a new biomarker?Semantic proximity Read

The molecular balancing act of p16(INK4a) in cancer and aging.Semantic proximity Read

p16 INK4A is a robust in vivo biomarker of cellular aging in human skinSemantic proximity Read

An updated landscape of cellular senescence heterogeneity: Mechanisms, technologies and senotherapiesSemantic proximity Read

Naturally occurring p16Ink4a-positive cells shorten healthy lifespanSemantic proximity Read

The number of p16INK4a positive cells in human skin reflects biological ageSemantic proximity Read

Expression of p16 INK4a in peripheral blood T-cells is a biomarker of human agingSemantic proximity Read

The role of aging in cancerSemantic proximity Read

Targeting p16INK4a-mediated cellular senescence as a therapeutic strategy for FLT3-ITD-driven acute myeloid leukemia.Semantic proximity Read